Therefore, investigating the role of EZH2 in regulating GFAP expression and astrocyte differentiation may offer a deeper understanding of the molecular pathways involved in glioma development and reveal promising strategies for therapeutic intervention. The gene discussed is EZH2; the disease is central nervous system cancer.